Preeclampsia screening from the patient's perspective

B Luchian, M Neagu, L Luchian, R Vladareanu, B Luchian, M Neagu, L Luchian, R Vladareanu

Abstract

Preeclampsia represents an important cause of maternal and fetal morbidity and mortality. The early identification of pregnant women at risk represents a priority in reducing preeclampsia complications. For a better evaluation of the importance of preeclampsia screening, a questionnaire was developed. Methods. The questionnaire based on 14 items was distributed online. The form was anonymously completed. All forms consisted of simple questions. Results. Data from 151 completed forms were collected and analyzed. The analysis revealed the importance of arterial pressure control. 15% of the responders needed hypertensive treatment in pregnancy. They were interested in completing the preeclampsia risk test (88%). Conclusions. The results suggested that preeclampsia screening and measurement of the atrial pressure may become a valuable tool for evaluating and for determining the diagnosis in question, but the possibility of emotional distress for the subjects at risk of developing the condition should be taken in consideration.

Keywords: hypertension; preeclampsia; questionnaire; responders.

Figures

Fig. 1
Fig. 1
Educational status
Fig. 2
Fig. 2
Age distribution
Fig. 3
Fig. 3
Blood pressure measurement
Fig. 4
Fig. 4
Blood pressure measurement in pregnancy

References

    1. East C, Conway K, Pollock W, Frawley N, Brennecke S. Women’s Experiences of Preeclampsia: Australian Action on Preeclampsia Survey of Women and Their Confidants. J Pregnancy. 2011;2011:375–653.
    1. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004;104(6):1367–1391.
    1. Wright D, Akolekar R, Syngelaki A, Poon LCY, Nicolaides KH. A competing risks model in early screening for preeclampsia. Fetal Diagn Ther. 2012;32(3):171–178.
    1. Rosser ML, Katz NT. Preeclampsia: An Obstetrician’s Perspective. Advances in Chronic Kidney Disease. 2013:287–296.
    1. Lyell DJ, Lambert-Messerlian GM, Giudice LC. Prenatal screening, epidemiology, diagnosis, and management of preeclampsia. Clin Lab Med. 2003;23(2):413–442.
    1. Park HJ, Shim SS, Cha DH. Combined screening for early detection of pre-eclampsia. Int J Mol Sci. 2015;16(8):17952–17974.
    1. Jašović-Siveska Emiija JV. Prediction of mild and severe preeclampsia with blood pressure measurements in first and second trimester of pregnancy Predykcja łagodnego i ciężkiego stanu przedrzucawkowego przy pomocy pomiarów ciśnienia tętniczego w I i II trymestrze ciąży. 2011:845–850.
    1. Harris JM, Franck L, Green B, Michie S. The psychological impact of providing women with risk information for pre-eclampsia: A qualitative study. Midwifery. Elsevier. 2014;30(12):1187–1195. .
    1. Jrgensen JM, Hedley PL, Gjerris M, Christiansen M. Ethical issues related to screening for preeclampsia. Bioethics. 2014;28(7):360–367.
    1. Service NH, Pregnancy COF. H Ypertension in Pregnancy Pre Eclampsia: Pre Conception Counselling for Women With a History of, or Significant Risk Factors. 2012:1–3.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe